RxDoctor Payments Data

Seung Choi, MD

Geriatric Medicine · Los Angeles, CANPI 1932145992

Payments from drug & device makers

$2,150in general payments, 2019–2025

Across 100 payments — averaging $21.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$610
  • Bayer$269
  • Lilly USA, LLC$259
  • Avanir Pharmaceuticals, Inc.$257
  • Sunovion Pharmaceuticals Inc.$143
  • Arbor Pharmaceuticals, Inc.$104
  • plus $508 from 14 others

What the payments were for

  • Food & beverage$2,150100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,150 in reported general payments places this provider in the 80th percentile of 494 geriatric medicine providers in California.

See all geriatric medicine providers in California

Medicare billing

Part B allowed, 2024
$29,923
Medicare patients
124
Services billed
266

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin181$109,096
EliquisApixaban141$57,616
OzempicSemaglutide45$46,957
XifaxanRifaximin22$31,957
SantylCollagenase Clostridium Hist.18$24,819
JanuviaSitagliptin Phosphate43$23,144
DescovyEmtricitabine/Tenofov Alafenam11$22,908
NuedextaDextromethorphan Hbr/Quinidine19$14,892
EntrestoSacubitril/Valsartan18$14,034
RestasisCyclosporine11$7,353
XareltoRivaroxaban14$7,115
Atrovent HfaIpratropium Bromide14$7,066
Atorvastatin Calcium391$4,808
RocklatanNetarsudil Mesylat/Latanoprost13$4,749
SimbrinzaBrinzolamide/Brimonidine Tart20$4,408

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$44$109,096181 claims
Novo NordiskOzempic$60$46,95745 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$610$31,95722 claims
Avanir Pharmaceuticals, Inc.Nuedexta$257$14,89219 claims
Astellas Pharma US IncMyrbetriq$45$3,00713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 494 geriatric medicine providers in California.

Other geriatric medicine in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →